GB1465684A — Contraceptive device
Assigned to Individual · Expires 1977-02-23 · 49y expired
What this patent protects
1465684 Intra-uterine contraceptive devices L C R EMMETT 2 April 1974 [27 July 1973] 35816/73 Heading A5R An intra-uterine contraceptive device comprises a resilient body which is "C" or capital omega shaped in the uterine cavity and elastically deformable into a linear c…
USPTO Abstract
1465684 Intra-uterine contraceptive devices L C R EMMETT 2 April 1974 [27 July 1973] 35816/73 Heading A5R An intra-uterine contraceptive device comprises a resilient body which is "C" or capital omega shaped in the uterine cavity and elastically deformable into a linear configuration for passage through the cervical canal. In Fig. 1, device 1 comprises a C-shaped member with arms 2, 3 and rounded, enlarged heads 4, 5 which may have holes for nylon threads 9, 10 to pass through, the threads may be knotted at 11. Opposite sides 6 of the heads, which may be of different sizes, are flattened providing parallel planar surfaces. The cross section of the member is oval, surface 7 having a smaller radius of curvature than surface 8. The device is moulded from elastic plastics e.g. polypropylene or 80% polyethylene with 20% barium sulphate. The distance between heads 4, 5 is 5-7 mm and the device diameter is 23-29 mm. A copper sleeve may fit on the member. A second device 20, see Fig. 3, has two enlarged heads 31, 32 connected by member 33 serrated at 34 to prevent bunching of a copper wire 35 whose ends are embedded in the member. Threads are knotted into countersunk holes (36) in the heads, the other thread ends being secured in a plastics bead 38. The wire surface area is 200-450 sq. mm. Member 33 is ellipsoidal with planar (39) and convex (40) surfaces. The device is 23-35 mm wide, 21-27 mm deep, has 3-15 mm between the heads which are 2.5-5 mm diameter and 2-4 mm thick. The device may be hollow and porous for dispensing hormones or spermicides The copper provides X-ray opacity, enhances contraception and diminishes inter-menstrual bleeding and pain, other metals may be used. To insert the device, the uterus is sounded and flange 43 moved to 2 cm from end 44. Device 20 is straightened, inserted into the tubular inserter 41 and pushed with plunger 45 to 1 cm short of end 44. Inserter 41 is passed through the vagina 12 into the endocervical canal 13 until flange 43 rests against the cervix 14. Inserter 41 is withdrawn 1 cm, rotated 90 and plunger 45 pushed to expel device 20 while holding bead 38. The plunger 45 is withdrawn from the inserter 41, the bead 38 pulled to draw the heads together and the inserter pushed up until flange 43 again contacts cervix 14 to site the device correctly in the fundal region of the uterus. Bead 38 is cut off, the inserter withdrawn and the threads trimmed at the cervix. To withdraw the device, one thread is pulled, the device straightens and travels through the cervical canal 13.
Drugs covered by this patent
- Arnicare Leg Cramps (COPPER) · Sebela Womens Hlth
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.